3,4-Dehydrodebrisoquine, a Novel Debrisoquine Metabolite Formed from 4-Hydroxydebrisoquine That Affects the CYP2D6 Metabolic Ratio-Reference-Cited by-同舟云学术

3,4-Dehydrodebrisoquine, a Novel Debrisoquine Metabolite Formed from 4-Hydroxydebrisoquine That Affects the CYP2D6 Metabolic Ratio

Published:2006-06-16 Issue:9 Volume:34 Page:1563-1574
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Zhen Yueying,Slanař Ondřej,Krausz Kristopher W.,Chen Chi,Slavík Josef,McPhail Kerry L.,Zabriskie T. Mark,Perlík František,Gonzalez Frank J.,Idle Jeffrey R.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference44 articles.

1. Metabolism of Debrisoquine Sulphate in Rat, Dog and Man

2. The Metabolism of Debrisoquine in Rat and Man

3. Metabolic oxidation phenotypes as markers for susceptibility to lung cancer

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolomics and Personalized Medicine;Advances in Protein Chemistry and Structural Biology;2016

2. Expression in yeast, new substrates, and construction of a first 3D model of human orphan cytochrome P450 2U1: Interpretation of substrate hydroxylation regioselectivity from docking studies;Biochimica et Biophysica Acta (BBA) - General Subjects;2015-07

3. A history and overview of phenotypic variability in CYP2D6 activity;CYP2D6: Genetics, Pharmacology and Clinical Relevance;2014-02

4. Towards Polypharmacokinetics: Pharmacokinetics of Multicomponent Drugs and Herbal Medicines Using a Metabolomics Approach;Evidence-Based Complementary and Alternative Medicine;2013

5. Interference by metabolites and the corresponding troubleshooting during the LC–MS/MS bioanalysis of G004, a bromine-containing hypoglycemic agent;Journal of Chromatography B;2012-06